Edit: that should be “unaccountable”. And when I say dwindling share price I meant it in the context of the Zoleo growth prospects. While BCCs revenues have been largely static the last few years (I don’t buy the double digit growth line as FY20 was down on FY19), the product and revenue mix is a lot more prospective now than previous years IMO although I concede there has been some market cap expansion.
Anyway, the point remains that the continued poor disclosure is harming the credibility of management and the share price.
Edit: that should be “unaccountable”. And when I say dwindling...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.09M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 79293 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 37492 | 2 |
View Market Depth
| Last trade - 11.37am 24/06/2025 (20 minute delay) ? |
| BCC (ASX) Chart |
Day chart unavailable